LRRK2 and Parkinson disease: Sonnien et al. observed increased production of LRRK2 mutant synaptophysin by astrocytes from α-mutant PD patients, altered metabolism and calcium homeostasis, increased cytokine release, increased levels of polyamines and their precursors, and decreased levels of lysophosphatidylethanolamine [35].